Literature DB >> 32373991

In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.

T Joshi1, T Joshi1, P Sharma, S Mathpal, H Pundir, V Bhatt, S Chandra.   

Abstract

OBJECTIVE: Currently, Coronavirus COVID-19 is spreading worldwide very rapidly and its control is very difficult because there is no effective vaccine or drugs available in markets. This virus can infect both animals and people and cause illnesses of the respiratory tract. WHO has declared Coronavirus as pandemic and the whole world is fighting against Coronavirus. Globally, more than 199,478 people have been diagnosed with COVID-19. As of March 18, 2020, more than 167 countries have been affected and more than 8000 deaths have been reported. The main country being affected is China followed by Italy, Iran, Spain, France, and the USA.
MATERIALS AND METHODS: Since there are no effective drugs available against Coronavirus, we conducted virtual screening of phytochemicals to find novel compounds against this virus. Hence, we created a phytochemical library of 318 phytochemicals from 11 plants which have been reported as antiviral, antibacterial and antifungal activity. The phytochemical library was subjected to virtual screening against molecular targets; Main protease (Mpro) and Angiotensin-Converting Enzyme 2 (ACE2).
RESULTS: Top 10 compounds were selected from each target which had better and significantly low binding energy as compared to the reference molecule.
CONCLUSIONS: Based on the binding energy score, we suggest that these compounds can be tested against Coronavirus and used to develop effective antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32373991     DOI: 10.26355/eurrev_202004_21036

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  42 in total

Review 1.  Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.

Authors:  Io Antonopoulou; Eleftheria Sapountzaki; Ulrika Rova; Paul Christakopoulos
Journal:  Comput Struct Biotechnol J       Date:  2022-03-14       Impact factor: 7.271

2.  Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study.

Authors:  Shafi Mahmud; Suvro Biswas; Gobindo Kumar Paul; Mohasana Akter Mita; Shamima Afrose; Md Robiul Hasan; Mst Sharmin Sultana Shimu; Mohammad Abu Raihan Uddin; Md Salah Uddin; Shahriar Zaman; K M Kaderi Kibria; Md Arif Khan; Talha Bin Emran; Md Abu Saleh
Journal:  Arab J Chem       Date:  2021-07-14       Impact factor: 5.165

Review 3.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

Review 4.  Natural products' role against COVID-19.

Authors:  Ananda da Silva Antonio; Larissa Silveira Moreira Wiedemann; Valdir Florêncio Veiga-Junior
Journal:  RSC Adv       Date:  2020-06-19       Impact factor: 4.036

Review 5.  Dietary Supplements for COVID-19.

Authors:  Gerard E Mullin; Berkeley Limektkai; Lin Wang; Patrick Hanaway; Loren Marks; Edward Giovannucci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  De novo biosynthesis of C-arabinosylated flavones by utilization of indica rice C-glycosyltransferases.

Authors:  Zhuo Chen; Yuwei Sun; Guangyi Wang; Ying Zhang; Qian Zhang; Yulian Zhang; Jianhua Li; Yong Wang
Journal:  Bioresour Bioprocess       Date:  2021-06-12

7.  Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation.

Authors:  Ting Xiao; Mengqi Cui; Caijuan Zheng; Ming Wang; Ronghao Sun; Dandi Gao; Jiali Bao; Shanfa Ren; Bo Yang; Jianping Lin; Xiaoping Li; Dongmei Li; Cheng Yang; Honggang Zhou
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

8.  In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.

Authors:  Phaedra Eleftheriou; Dionysia Amanatidou; Anthi Petrou; Athina Geronikaki
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

9.  Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.

Authors:  Tanuja Joshi; Tushar Joshi; Hemlata Pundir; Priyanka Sharma; Shalini Mathpal; Subhash Chandra
Journal:  J Biomol Struct Dyn       Date:  2020-08-05

10.  Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.

Authors:  Sk Abdul Amin; Suvankar Banerjee; Kalyan Ghosh; Shovanlal Gayen; Tarun Jha
Journal:  Bioorg Med Chem       Date:  2020-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.